undefined
The trademark application Ustemab was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on October 15, 2020, and it was registered by office on January 22, 2021 without any oppositions.
The application was filed in Swedish (German was selected as the second language).